Chief Executive Officer,
Burrill and Company
G. Steven Burrill heads Burrill & Company, a life sciences merchant bank engaged in venture capital and strategic partnering. He also is a member of the World Bank's "Out of the Box" group and an adjunct professor at the University of California, San Francisco. Before founding Burrill & Company in 1994, he spent 28 years with Ernst & Young coordinating services to clients in the biotechnology and life sciences industries and in high technology/manufacturing worldwide.
Mr. Burrill chaired the National Research Council study on linkages in biotechnology between Japan and the United States. He also was involved with the US-Japan Science and Technology Agreement Study of Technology Transfer Mechanisms between the US and Japan.
A current board member of a number of biotech companies, Mr. Burrill chairs the boards of Pyxis Genomics and Paradigm Genetics. He also serves on the boards of the Bay Area Bioscience Center, the Bay Area Science Infrastructure Consortium, the California Healthcare Institute, the Exploratorium, the Kellogg Center for Biotechnology, and the Foundation for the National Medals of Science and Technology, which he helped found.
Mr. Burrill has written many articles and books, including his most recent industry report, Biotech 2003: Life Sciences‹Revaluation and Restructuring. He is a regular columnist for BioPharm, American Genomics and Proteomics Technology, and the Journal of BioLaw and Business and serves on the advisory editorial board of BioPeople. In 2002 Scientific American recognized him as a biotech investment visionary.
Mr. Burrill earned his B.B.A. in accounting and finance from the University of Wisconsin.